The Role of Perivascular Adipose Tissue in the Pathogenesis of Endothelial Dysfunction in Cardiovascular Diseases and Type 2 Diabetes Mellitus
- PMID: 38002006
- PMCID: PMC10669084
- DOI: 10.3390/biomedicines11113006
The Role of Perivascular Adipose Tissue in the Pathogenesis of Endothelial Dysfunction in Cardiovascular Diseases and Type 2 Diabetes Mellitus
Abstract
Cardiovascular diseases (CVDs) and type 2 diabetes mellitus (T2DM) are two of the four major chronic non-communicable diseases (NCDs) representing the leading cause of death worldwide. Several studies demonstrate that endothelial dysfunction (ED) plays a central role in the pathogenesis of these chronic diseases. Although it is well known that systemic chronic inflammation and oxidative stress are primarily involved in the development of ED, recent studies have shown that perivascular adipose tissue (PVAT) is implicated in its pathogenesis, also contributing to the progression of atherosclerosis and to insulin resistance (IR). In this review, we describe the relationship between PVAT and ED, and we also analyse the role of PVAT in the pathogenesis of CVDs and T2DM, further assessing its potential therapeutic target with the aim of restoring normal ED and reducing global cardiovascular risk.
Keywords: cardiovascular diseases (CVDs); endothelial dysfunction (ED); insulin resistance (IR); non-communicable diseases (NCDs); perivascular adipose tissue (PVAT); type 2 diabetes mellitus (T2DM).
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Inflamed Adipose Tissue: Therapeutic Targets for Obesity-related Endothelial Injury.Endocrinology. 2023 Jun 6;164(7):bqad094. doi: 10.1210/endocr/bqad094. Endocrinology. 2023. PMID: 37289080 Review.
-
Perivascular adipose tissue in age-related vascular disease.Ageing Res Rev. 2020 May;59:101040. doi: 10.1016/j.arr.2020.101040. Epub 2020 Feb 26. Ageing Res Rev. 2020. PMID: 32112889 Review.
-
Perivascular adipose tissue, inflammation and insulin resistance: link to vascular dysfunction and cardiovascular disease.Horm Mol Biol Clin Investig. 2015 Apr;22(1):19-26. doi: 10.1515/hmbci-2015-0010. Horm Mol Biol Clin Investig. 2015. PMID: 25941914 Review.
-
Increased inflammation, oxidative stress and a reduction in antioxidant defense enzymes in perivascular adipose tissue contribute to vascular dysfunction in type 2 diabetes.Free Radic Biol Med. 2020 Jan;146:264-274. doi: 10.1016/j.freeradbiomed.2019.11.002. Epub 2019 Nov 5. Free Radic Biol Med. 2020. PMID: 31698080
-
Luteolin Improves Perivascular Adipose Tissue Profile and Vascular Dysfunction in Goto-Kakizaki Rats.Int J Mol Sci. 2021 Dec 20;22(24):13671. doi: 10.3390/ijms222413671. Int J Mol Sci. 2021. PMID: 34948468 Free PMC article.
Cited by
-
Sex-Specific Characteristics of Perivascular Fat in Aortic Aneurysms.J Clin Med. 2025 Apr 29;14(9):3071. doi: 10.3390/jcm14093071. J Clin Med. 2025. PMID: 40364103 Free PMC article. Review.
-
The impact of perivascular adipose tissue characteristics on incident cardiovascular events in non-dialysis chronic kidney disease patients.Front Med (Lausanne). 2025 Jun 20;12:1547007. doi: 10.3389/fmed.2025.1547007. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40620434 Free PMC article.
-
Current Understanding of Cardiovascular Calcification in Patients with Chronic Kidney Disease.Int J Mol Sci. 2024 Sep 23;25(18):10225. doi: 10.3390/ijms251810225. Int J Mol Sci. 2024. PMID: 39337709 Free PMC article. Review.
-
Effect of Pioglitazone on Endoplasmic Reticulum Stress and Autophagy Response in the Perivascular Adipose Tissue of Type 2 Diabetic Rats.PPAR Res. 2025 Mar 21;2025:9645836. doi: 10.1155/ppar/9645836. eCollection 2025. PPAR Res. 2025. PMID: 40160239 Free PMC article.
-
Perivascular adipose tissue dysfunction contributes to thoracic aortic aneurysm development.Cardiovasc Diabetol. 2025 May 21;24(1):223. doi: 10.1186/s12933-025-02765-x. Cardiovasc Diabetol. 2025. PMID: 40399937 Free PMC article.
References
-
- World Health Organization Noncommunicable Diseases (NCD) 2019. [(accessed on 29 June 2023)]. Available online: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases.
-
- World Health Organization . Noncommunicable Diseases Country Profiles 2018. World Health Organization; Geneva, Switzerland: 2018.
-
- WHO Regional Office for Europe . Monitoring Noncommunicable Disease Commitments in Europe 2021: Are We on Track to Reach Targets 10 Years after the Moscow Declaration and First United Nations High-Level Meeting? WHO Regional Office for Europe; Copenhagen, Denmark: 2021.
Publication types
LinkOut - more resources
Full Text Sources